1. Home
  2. CELZ vs GLMD Comparison

CELZ vs GLMD Comparison

Compare CELZ & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Medical Technology Holdings Inc.

CELZ

Creative Medical Technology Holdings Inc.

HOLD

Current Price

$0.74

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo Galmed Pharmaceuticals Ltd.

GLMD

Galmed Pharmaceuticals Ltd.

HOLD

Current Price

$0.53

Market Cap

4.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CELZ
GLMD
Founded
1998
2000
Country
United States
Israel
Employees
4
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.2M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
CELZ
GLMD
Price
$0.74
$0.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.8M
192.2K
Earning Date
05-08-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
32.08
N/A
EPS
N/A
N/A
Revenue
$6,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.41
52 Week High
$6.25
$1.80

Technical Indicators

Market Signals
Indicator
CELZ
GLMD
Relative Strength Index (RSI) 27.03 46.21
Support Level N/A $0.41
Resistance Level $0.93 $0.70
Average True Range (ATR) 0.07 0.06
MACD 0.03 0.00
Stochastic Oscillator 8.08 40.46

Price Performance

Historical Comparison
CELZ
GLMD

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.

Share on Social Networks: